39025911000001107: Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\UK product\Virtual medicinal product\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\UK product\Virtual therapeutic moiety\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\UK product\Trade family\Exelon\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing acetylcholinesterase inhibitor (product)\Product containing centrally acting acetylcholinesterase inhibitor\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing organic acid and/or organic acid derivative (product)\Product containing carboxylic acid and/or carboxylic acid derivative (product)\Product containing carbamate\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\Medicinal product\Product containing autonomic agent\Product containing parasympathomimetic agent (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing centrally acting acetylcholinesterase inhibitor\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)
\Medicinal product\Product containing autonomic agent\Product containing parasympathomimetic agent (product)\Product containing acetylcholinesterase inhibitor (product)\Product containing reversible anticholinesterase\Product containing rivastigmine\Rivastigmine\Rivastigmine 13.3mg/24hours transdermal patches\Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

1616651000001118 Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1616661000001115 Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) parallel import indicator	Parallel import	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Is a	Rivastigmine 13.3mg/24hours transdermal patches	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Is a	Exelon	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has specific active ingredient	Rivastigmine	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has dispensed dose form	Prolonged-release transdermal patch	true	Inferred relationship	Existential restriction modifier
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) 30 patch	Has AMP	True	Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
1616651000001118	Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
1616661000001115	Exelon 13.3mg/24hours transdermal patches (CST Pharma Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module